Startseite Medizin The effects of curcumin-containing supplementations on inflammatory markers and lipid profiles in patients with chronic kidney diseases: a systematic review and meta-analysis of randomized controlled trials
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

The effects of curcumin-containing supplementations on inflammatory markers and lipid profiles in patients with chronic kidney diseases: a systematic review and meta-analysis of randomized controlled trials

  • Farzaneh Futuhi , Ahmad Naghibzadeh Tahami , Jalal Azmandian und Azadeh Saber EMAIL logo
Veröffentlicht/Copyright: 3. Juni 2022

Abstract

Objectives

An evaluation the effects of curcumin on inflammatory markers and lipid profiles among patients with chronic kidney diseases (CKD).

Methods

The electronic databases such as PubMed, and Scopus were searched systematically up until 12 December 2021. To evaluate the quality of the included studies, the Cochrane risk-of-bias tool for randomized trials was utilized. Likewise, data pooling was performed using a random effects model, also called a variance components model. Also, the findings were calculated as weighted mean difference (WMD) with a 95% confidence interval (CI).

Results

In the end, this meta-analysis comprised a total number of nine studies. Curcumin intake significantly reduced total cholesterol (TC) (WMD=−13.77 mg/dL; 95% CI, −26.77, −0.77; p=0.04) and tumor necrosis factor alpha (TNF-α) (WMD=−18.87 pg/mL; 95% CI, −28.36, −9.38; p<0.001) compared with controls. The results did not confirm the significant effect of curcumin intake on triglyceride (TG) (WMD=−6.37 mg/dL; 95% CI, −26.59, 13.85; p=0.54), low-density lipoproteins (LDL-C) (WMD=−5.65 mg/dL; 95% CI, −20.81, 9.50; p=0.46), high-density lipoprotein (HDL-C) (WMD=0.16 mg/dL; 95% CI, −2.55, 2.88; p=0.91), and C-reactive protein (CRP) (WMD=−0.13 mg/L; 95% CI, −3.25, 3.30; p=0.93).

Conclusions

Our study showed that curcumin significantly impacts TC and TNF levels in CKD patients.


Corresponding author: Dr. Azadeh Saber, Assistant Professor of Nephrology, Physiology Research Center, Endocrinology and Metabolism Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran, Phone: +98 9133425691, Fax: +98 32263857, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: This study was approved by the Ethics Committee of Kerman University of Medical Sciences (KUMS) with ID code IR.KMU.REC.1400.614.

References

1. Forni Ogna, V, Ogna, A, Ponte, B, Gabutti, L, Binet, I, Conen, D, et al.. Prevalence and determinants of chronic kidney disease in the Swiss population. Swiss Med Wkly 2016;146:w14313. https://doi.org/10.4414/smw.2016.14313.Suche in Google Scholar PubMed

2. Garcia-Garcia, G, Jha, V. Chronic kidney disease in disadvantaged populations. Braz J Med Biol Res 2015;48:377–81.10.1590/1414-431x20144519Suche in Google Scholar PubMed PubMed Central

3. Himmelfarb, J, Stenvinkel, P, Ikizler, TA, Hakim, RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002;62:1524–38. https://doi.org/10.1046/j.1523-1755.2002.00600.x.Suche in Google Scholar PubMed

4. Moradi, H, Sica, DA, Kalantar-Zadeh, K. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease. Am J Nephrol 2013;38:136–48. https://doi.org/10.1159/000351758.Suche in Google Scholar PubMed

5. Ayodele, OE, Alebiosu, CO. Burden of chronic kidney disease: an international perspective. Adv Chronic Kidney Dis 2010;17:215–24. https://doi.org/10.1053/j.ackd.2010.02.001.Suche in Google Scholar PubMed

6. Obi, Y, Kim, T, Kovesdy, CP, Amin, AN, Kalantar-Zadeh, K. Current and potential therapeutic strategies for hemodynamic cardiorenal syndrome. Cardiorenal Med 2016;6:83–98. https://doi.org/10.1159/000441283.Suche in Google Scholar PubMed PubMed Central

7. Okamura, DM, Pennathur, S. The balance of powers: redox regulation of fibrogenic pathways in kidney injury. Redox Biol 2015;6:495–504. https://doi.org/10.1016/j.redox.2015.09.039.Suche in Google Scholar PubMed PubMed Central

8. Vafadar_afshar, G, Khadem-Ansari, M-H, Makhdomii, K, Rasooli, J. The effects of nano-curcumin supplementation on serum level of hs-CRP, adhesion molecules, and lipid profiles in hemodialysis patients, a randomized controlled clinical trial. Iran J Kidney Dis 2020;14:52.Suche in Google Scholar

9. Yao, Q, Axelsson, J, Stenvinkel, P, Lindholm, B. Chronic systemic inflammation in dialysis patients: an update on causes and consequences. Am Soc Artif Intern Organs J 2004;50:Iii–Ivii. https://doi.org/10.1097/01.mat.0000147958.87989.eb.Suche in Google Scholar PubMed

10. Filiopoulos, V, Vlassopoulos, D. Inflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomes. Inflamm Allergy – Drug Targets 2009;8:369–82. https://doi.org/10.2174/1871528110908050369.Suche in Google Scholar PubMed

11. Meuwese, CL, Stenvinkel, P, Dekker, FW, Carrero, JJ. Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat Rev Nephrol 2011;7:166–76. https://doi.org/10.1038/nrneph.2011.2.Suche in Google Scholar PubMed

12. Cohen, SD, Phillips, TM, Khetpal, P, Kimmel, PL. Cytokine patterns and survival in haemodialysis patients. Nephrol Dial Transplant 2010;25:1239–43. https://doi.org/10.1093/ndt/gfp625.Suche in Google Scholar PubMed

13. Rysz, J, Banach, M, Cialkowska-Rysz, A, Stolarek, R, Barylski, M, Drozdz, J, et al.. Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis. Membranes 2006;2:3.Suche in Google Scholar

14. Levey, AS, Greene, T, Kusek, JW, Beck, GJ, Group, MS. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000;11(2 Suppl):155.Suche in Google Scholar

15. Seirafian, S, Tabatabaei, P. Evaluation of lipid profile changes in patients during one year after the onset of peritoneal dialysis. J Isfahan Med School 2020;38:121–8.Suche in Google Scholar

16. Pulido-Moran, M, Moreno-Fernandez, J, Ramirez-Tortosa, C, Ramirez-Tortosa, M. Curcumin and health. Molecules 2016;21:264. https://doi.org/10.3390/molecules21030264.Suche in Google Scholar PubMed PubMed Central

17. Zhou, H, Beevers, SC, Huang, S. The targets of curcumin. Curr Drug Targets 2011;12:332–47. https://doi.org/10.2174/138945011794815356.Suche in Google Scholar PubMed PubMed Central

18. Ali, BH, Marrif, H, Noureldayem, SA, Bakheit, AO, Blunden, G. Some biological properties of curcumin: a review. Nat Prod Commun 2006;1. https://doi.org/10.1177/1934578x0600100613.Suche in Google Scholar

19. Jie, Z, Chao, M, Jun, A, Wei, S, LiFeng, M. Effect of curcumin on diabetic kidney disease: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Evid Base Compl Alternative Med 2021;2021. https://doi.org/10.1155/2021/6109406.Suche in Google Scholar PubMed PubMed Central

20. Gupta, SC, Patchva, S, Koh, W, Aggarwal, BB. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 2012;39:283–99. https://doi.org/10.1111/j.1440-1681.2011.05648.x.Suche in Google Scholar PubMed PubMed Central

21. Trujillo, J, Chirino, YI, Molina-Jijón, E, Andérica-Romero, AC, Tapia, E, Pedraza-Chaverrí, J. Renoprotective effect of the antioxidant curcumin: recent findings. Redox Biol 2013;1:448–56. https://doi.org/10.1016/j.redox.2013.09.003.Suche in Google Scholar PubMed PubMed Central

22. Agharazii, M, St-Louis, R, Gautier-Bastien, A, Ung, R-V, Mokas, S, Larivière, R, et al.. Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification. Am J Hypertens 2015;28:746–55. https://doi.org/10.1093/ajh/hpu225.Suche in Google Scholar PubMed

23. Borenstein, M, Hedges, LV, Higgins, JPT, Rothstein, HR. Introduction to meta-analysis. New York City: John Wiley & Sons; 2021.10.1002/9781119558378Suche in Google Scholar

24. Higgins, JPT. Cochrane handbook for systematic reviews of interventions version 5.0.1. New York City: The Cochrane Collaboration; 2008. Available from: http://www.cochrane-handbook.org.10.1002/9780470712184Suche in Google Scholar

25. Duval, S, Tweedie, R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455–63. https://doi.org/10.1111/j.0006-341x.2000.00455.x.Suche in Google Scholar PubMed

26. Jiménez-Osorio, AS, García-Niño, WR, González-Reyes, S, Álvarez-Mejía, AE, Guerra-León, S, Salazar-Segovia, J, et al.. The effect of dietary supplementation with curcumin on redox status and Nrf2 activation in patients with nondiabetic or diabetic proteinuric chronic kidney disease: a pilot study. J Ren Nutr 2016;26:237–44. https://doi.org/10.1053/j.jrn.2016.01.013.Suche in Google Scholar PubMed

27. Vafadar‐Afshar, G, Rasmi, Y, Yaghmaei, P, Khadem‐Ansari, MH, Makhdoomi, K, Rasouli, J. The effects of nanocurcumin supplementation on inflammation in hemodialysis patients: a randomized controlled trial. Hemodial Int 2021;25:232–9. https://doi.org/10.1111/hdi.12911.Suche in Google Scholar PubMed

28. Samadian, F, Dalili, N, Gholi, FP-R, Fattah, M, Malih, N, Nafar, M, et al.. Evaluation of curcumin’s effect on inflammation in hemodialysis patients. Clin Nutr ESPEN 2017;22:19–23. https://doi.org/10.1016/j.clnesp.2017.09.006.Suche in Google Scholar PubMed

29. Rodrigues, HCN, Martins, TFP, Braga, CC, Silva, MAC, da Cunha, LC, de Araújo Sugizaki, CS, et al.. Antioxidant and anti-inflammatory response to curcumin supplementation in hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr ESPEN 2021;44:136–42. https://doi.org/10.1016/j.clnesp.2021.06.006.Suche in Google Scholar PubMed

30. Alvarenga, L, Salarolli, R, Cardozo, LFMF, Santos, RS, de Brito, JS, Kemp, JA, et al.. Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: a pilot randomized, double-blind, controlled study. Clin Nutr 2020;39:3594–600. https://doi.org/10.1016/j.clnu.2020.03.007.Suche in Google Scholar PubMed

31. Moreillon, JJ, Bowden, RG, Deike, E, Griggs, J, Wilson, R, Shelmadine, B, et al.. The use of an anti-inflammatory supplement in patients with chronic kidney disease. J Compl Integr Med 2013;10:143–52. https://doi.org/10.1515/jcim-2012-0011.Suche in Google Scholar PubMed

32. Shafabakhsh, R, Asemi, Z, Reiner, Ž, Soleimani, A, Aghadavod, E, Bahmani, F. The effects of nano-curcumin on metabolic status in patients with diabetes on hemodialysis, a randomized, double blind, placebo-controlled trial. Iran J Kidney Dis 2020;14:290–9.Suche in Google Scholar

33. Ortiz, BOM, Preciado, ARF, Emiliano, JR, Garza, SM, Rodríguez, ER, de Alba Macías, LA. Recovery of bone and muscle mass in patients with chronic kidney disease and iron overload on hemodialysis and taking combined supplementation with curcumin and resveratrol. Clin Interv Aging 2019;14:2055. https://doi.org/10.2147/cia.s223805.Suche in Google Scholar

34. Pagano, E, Romano, B, Izzo, AA, Borrelli, F. The clinical efficacy of curcumin-containing nutraceuticals: an overview of systematic reviews. Pharmacol Res 2018;134:79–91. https://doi.org/10.1016/j.phrs.2018.06.007.Suche in Google Scholar PubMed

35. Ali, BH, Al-Salam, S, Al Suleimani, Y, Al Kalbani, J, Al Bahlani, S, Ashique, M, et al.. Curcumin ameliorates kidney function and oxidative stress in experimental chronic kidney disease. Basic Clin Pharmacol Toxicol 2018;122:65–73.10.1111/bcpt.12817Suche in Google Scholar PubMed

36. de Almeida Alvarenga, L, Leal, VDO, Borges, NA, Silva de Aguiar, A, Faxén-Irving, G, Stenvinkel, P, et al.. Curcumin - a promising nutritional strategy for chronic kidney disease patients. J Funct Foods 2018;40:715–21. https://doi.org/10.1016/j.jff.2017.12.015.Suche in Google Scholar

37. Ghosh, SS, Gehr, TW, Ghosh, S. Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase. Molecules 2014;19:20139–56. https://doi.org/10.3390/molecules191220139.Suche in Google Scholar PubMed PubMed Central

38. Ghelani, H, Razmovski-Naumovski, V, Chang, D, Nammi, S. Chronic treatment of curcumin improves hepatic lipid metabolism and alleviates the renal damage in adenine-induced chronic kidney disease in Sprague-Dawley rats. BMC Nephrol 2019;20:1–13. https://doi.org/10.1186/s12882-019-1621-6.Suche in Google Scholar PubMed PubMed Central

Received: 2022-03-18
Accepted: 2022-05-15
Published Online: 2022-06-03

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Reviews
  3. Evidence implementation among complementary medicine practitioners: a meta-summary
  4. Phytochemical: a treatment option for heavy metal induced neurotoxicity
  5. The effects of curcumin-containing supplementations on inflammatory markers and lipid profiles in patients with chronic kidney diseases: a systematic review and meta-analysis of randomized controlled trials
  6. A systematic review on traditional medicinal Animal’s parts and products used for the treatment of respiratory tract disorders in Ethiopia
  7. Review on nutraceuticals: phase transition from preventive to protective care
  8. A study of effect of Centella asiatica on oxidative markers in the hippocampus of offsprings born to alcohol-fed pregnant rats and the correlation with their cognitive functions
  9. Anxiogenic and anxiolytic effects of memantine injected into the ventral hippocampus in male stressed mice
  10. Research Articles
  11. Comparison of antithyroid effects and hepatic complications of methimazole with catechin and its nanoencapsulation form in adult male rats
  12. Almond oil restores blood parameters, liver function, blood and liver antioxidants and DNA, and liver histology more efficiently than olive oil in favism
  13. Highly efficient microencapsulation of phytonutrients by fractioned cellulose using biopolymer complexation technology
  14. Ocimum basilicum alleviates blood glucose, lipid profile and iNOS in diabetes gestational rat model
  15. Blood pressure and blood sugar-lowering effects of purified gambir on diabetic hypertensive Wistar Kyoto rats
  16. Assessment of anti-inflammatory and antioxidant activity of quercetin–rutin blend (SophorOx™) – an invitro cell based assay
  17. Subchronic toxicological evaluation of EnXtra™ (standardised extract of Alpinia galanga rhizome) in rats
  18. Ficus glumosa Del. reduces phenylhydrazine-induced hemolytic anaemia and hepatic damage in Wistar rats
  19. Screening of anti-cancerous potential of classical Raudra rasa and modified Raudra rasa modified with hiraka bhasma (nanodiamond) through FTIR & LC-MS analysis
  20. Aqueous extract of Pedalium murex D. Royen ex L. leafy stem protects against lead induced testicular toxicity in Wistar rats
  21. Intrahippocampal co-administration of nicotine and O-acetyl-L-carnitine prevents the H-89-induced spatial learning deficits in Morris water maze
  22. Developmental effects of early-life stress on dopamine D2 receptor and proteins involved in noncanonical D2 dopamine receptor signaling pathway in the prefrontal cortex of male rats
  23. Probiotic administration enhanced antitrypanosomal effects of diminazene aceturate in dogs experimentally infected with Trypanosoma brucei brucei
  24. Acacia arabica (Lam.) Willd. On osteoblastogenesis, osteoblast proliferation, osteoclastic activity, and bone calcium mineralization
  25. GC-MS analysis of curculigo orchiodes and medicinal herbs with cytotoxic, hepatoprotective attributes of ethanolic extract from Indian origin
  26. Biochemical and histopathological evaluation of liver, kidney, and pancreas in normal Sprague Dawley rats administered aqueous extract of beetroot (Beta vulgaris)
  27. The effectiveness of emotional freedom techniques (EFT) on depression of postmenopausal women: a randomized controlled trial
  28. The formulation and efficacy of topical Dorema ammoniacum in treating Melasma: a randomized double-blind, placebo-controlled trial
  29. Impact of inhalation aromatherapy with Damask Rose (Rosa damascena) on stress, anxiety and hemodynamic parameters of patients undergoing coronary angiography: a single blind randomized clinical trial
  30. Hydro-alcoholic extract of Morus nigra reduces fasting blood glucose and HbA1c% in diabetic patients, probably via competitive and allosteric interaction with alpha-glucosidase enzyme; a clinical trial and in silico analysis
  31. Prophylactic management of radiation-induced mucositis using herbal mouthwash in patients with head and neck cancer: an assessor-blinded randomized controlled trial
  32. Implementation science in New Zealand naturopathic practice: a cross-sectional study
  33. Issues of mindfulness implementation for oncology caregivers
  34. Immediate effect of cold mud pack therapy on autonomic variables in primary hypertensive individuals: a randomized trial
  35. Effect of a Persian metabolic diet on the functional dyspepsia symptoms in patients with postprandial distress syndrome: a randomized, double-blind clinical trial
Heruntergeladen am 4.2.2026 von https://www.degruyterbrill.com/document/doi/10.1515/jcim-2022-0082/html
Button zum nach oben scrollen